On Monday, Akoya Biosciences Inc (NASDAQ: AKYA) was -4.88% drop from the session before settling in for the closing price of $2.46. A 52-week range for AKYA has been $1.88 – $6.31.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 23.82% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 23.38%. With a float of $20.61 million, this company’s outstanding shares have now reached $49.52 million.
In an organization with 330 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 55.56%, operating margin of -52.17%, and the pretax margin is -66.62%.
Akoya Biosciences Inc (AKYA) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Akoya Biosciences Inc stocks. The insider ownership of Akoya Biosciences Inc is 58.42%, while institutional ownership is 25.47%. The most recent insider transaction that took place on Jun 11 ’24, was worth 15,630. In this transaction President and CEO of this company sold 7,500 shares at a rate of $2.08, taking the stock ownership to the 224,733 shares. Before that another transaction happened on Jun 06 ’24, when Company’s President and CEO sold 7,500 for $2.01, making the entire transaction worth $15,064. This insider now owns 224,733 shares in total.
Akoya Biosciences Inc (AKYA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.86% during the next five years compared to -37.60% drop over the previous five years of trading.
Akoya Biosciences Inc (NASDAQ: AKYA) Trading Performance Indicators
You can see what Akoya Biosciences Inc (AKYA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of Akoya Biosciences Inc (AKYA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.43 million. That was inferior than the volume of 1.16 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 4.88%. Additionally, its Average True Range was 0.20.
During the past 100 days, Akoya Biosciences Inc’s (AKYA) raw stochastic average was set at 24.47%, which indicates a significant increase from 3.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.68% in the past 14 days, which was lower than the 87.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.56, while its 200-day Moving Average is $2.64. However, in the short run, Akoya Biosciences Inc’s stock first resistance to watch stands at $2.44. Second resistance stands at $2.54. The third major resistance level sits at $2.60. If the price goes on to break the first support level at $2.27, it is likely to go to the next support level at $2.21. The third support level lies at $2.11 if the price breaches the second support level.
Akoya Biosciences Inc (NASDAQ: AKYA) Key Stats
There are 49,573K outstanding shares of the company, which has a market capitalization of 116.00 million. As of now, sales total 96,630 K while income totals -63,320 K. Its latest quarter income was 18,810 K while its last quarter net income were -10,530 K.
